Catheter Precision (VTAK) Net Income towards Common Stockholders (2017 - 2026)
Catheter Precision (VTAK) posted quarterly Net Income towards Common Stockholders of -$3.0 million for Q1 2026, up 24.82% year-over-year from -$2.4 million in Q1 2025, and down 721.89% quarter-over-quarter from -$370000.0 in Q4 2025.
Catheter Precision (VTAK) Net Income towards Common Stockholders (2017 - 2026) Analysis & Trends
Catheter Precision (VTAK) has reported Net Income towards Common Stockholders for 10 consecutive years, with -$3.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders rose 24.82% year-over-year to -$3.0 million; the TTM figure through Mar 2026 stood at -$12.0 million (up 19.26% YoY), while the FY2025 annual figure was -$17.2 million, up 21.18% from the prior year.
- Net Income towards Common Stockholders fell to -$3.0 million in Q1 2026 per VTAK's latest filing, from -$370000.0 in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$6967.0 in Q1 2022 and bottomed at -$67.4 million in Q1 2023.
- Historically, Net Income towards Common Stockholders has averaged -$7.4 million across 5 years, with a median of -$2.7 million in 2024.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders soared 99.81% — and 2023, when it slumped 966887.23%.
- Catheter Precision's Net Income towards Common Stockholders stood at -$18.4 million in 2022, then surged by 97.29% to -$499000.0 in 2023, then tumbled by 398.4% to -$2.5 million in 2024, then soared by 85.12% to -$370000.0 in 2025, then sank by 721.89% to -$3.0 million in 2026.
- Business Quant data shows VTAK's Net Income towards Common Stockholders at -$3.0 million in Q1 2026, -$370000.0 in Q4 2025, and -$2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Catheter Precision | 564,834.50 | -1.27 Mn | 98,000.00 | -2.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.04 Mn |
| Dec 31, 2025 | -370,000.00 |
| Sep 30, 2025 | -2.19 Mn |
| Jun 30, 2025 | -6.41 Mn |
| Mar 31, 2025 | -4.05 Mn |
| Dec 31, 2024 | -2.49 Mn |
| Sep 30, 2024 | -4.12 Mn |
| Jun 30, 2024 | -4.22 Mn |
| Mar 31, 2024 | -2.68 Mn |
| Dec 31, 2023 | -499,000.00 |
| Sep 30, 2023 | -1.93 Mn |
| Jun 30, 2023 | -1.58 Mn |
| Mar 31, 2023 | -67.37 Mn |
| Dec 31, 2022 | -18.39 Mn |
| Sep 30, 2022 | -6.30 Mn |
| Jun 30, 2022 | -9,906.00 |
| Mar 31, 2022 | -6,967.00 |
| Dec 31, 2021 | -530,000.00 |
| Sep 30, 2021 | 3.08 Mn |
| Jun 30, 2021 | -5.25 Mn |